\
&
Contact us
\
&
Contact us
Published on | 3 years ago
ProgrammesThe 23/24 Work Programme is expected to be ready towards the end of the year.
Using the currently available information, the following timeline is the best prediction we can make:
So, the publication and opening of the first calls is expected in December 2022 and/or January 2023, most likely with submission deadlines as from April.
Want to have a sneak peak at the work programme already? You can find a draft on Science|Business.
Want to provide feedback on the draft? Stakeholders located in Flanders can turn to Geert Van Grootel, who is our Programme Committee delegates of the Department of Economy, Science and Innovation for cluster4.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The EU introduced a new ICT Supply Chain Security Toolbox, providing an EU approach to identify, assess, and mitigate cybersecurity risks across ICT supply chains. The toolbox will help Member States and public and private actors to bolster the security of ICT supply chains in the EU as set out in the revised Cybersecurity Act presented... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
